Great Elm Capital Corp. (GECC) earnings per share

Annual history
Fiscal years 2022 – 2025
USD / SHARE 6 PERIODS
Period End Diluted Filed
FY 2025 2025-12-31 -$2.57 2026-03-02
FY 2024 2024-12-31 $0.36 2025-03-10
FY 2023 2023-12-31 $3.33 2024-02-29
FY 2022 2022-12-31 -$2.49 2023-03-02
FY 2022 2021-12-31 -$2.52 2023-03-02
FY 2022 2020-12-31 -$14.41 2023-03-02
Quarterly history
Fiscal years 2022 – 2026
USD / SHARE 19 PERIODS
Period End Diluted Filed
Q1 2026 2026-03-31 -$0.05 2026-05-04
Q4 2025 2025-12-31 -$1.74 2026-03-02
Q3 2025 2025-09-30 -$1.79 2025-11-04
Q2 2025 2025-06-30 $1.02 2025-08-04
Q1 2025 2025-03-31 $0.04 2025-05-05
Q4 2024 2024-12-31 $0.18 2025-03-10
Q3 2024 2024-09-30 $0.33 2024-10-31
Q2 2024 2024-06-30 -$0.14 2024-08-01
Q1 2024 2024-03-31 -$0.05 2024-05-02
Q4 2023 2023-12-31 $0.56 2024-02-29
Q3 2023 2023-09-30 $1.02 2023-11-02
Q2 2023 2023-06-30 $0.68 2023-08-03
Q3 2023 2023-03-31 $1.07 2023-05-04
Q4 2022 2022-12-31 -$1.06 2023-03-02
Q3 2022 2022-09-30 $0.18 2022-11-03
Q2 2023 2022-06-30 -$0.87 2023-08-03
Q3 2023 2022-03-31 $1.12 2023-05-04
Q4 2022 2021-12-31 -$5.54 2023-03-02
Q3 2022 2021-09-30 -$0.79 2022-11-03

Methodology

Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (2 split s since 2020).

For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.

GECC CIK 0001675033 Source: EDGAR filings · all facts

Related tickers

RAPP

Rapport Therapeutics, Inc.

ARLO

ARLO TECHNOLOGIES, INC.

GWLL

Goldenwell Biotech, Inc.